Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category on the 2025 Fortune® World’s Most Admired ...

Clinical research company IQVIA (NYSE: IQV) in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand ...

To learn more, visit www.iqvia.com. PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The ...

It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set ... Piero Cingari IQVIA Delivers Solid Q4 Growth ...

Concussions were down 17 percent from 2023 and were the lowest on record since the league started tracking data in 2015.

Amsterdam, the Netherlands, 28 January 2025 - Freya Pharma Solutions, [Freya Pharma, or the Company], a pharmaceutical ...

The S&P 500 Index ($SPX) (SPY) today is up +0.29%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.12%, and the Nasdaq ...

Its CEO at the time, David Coman, was a former executive at the Durham-based Quintiles (now IQVIA). In March ... have failed to achieve their initial jobs promises since North Carolina launched ...

IQVIA to create northern 'Prime Site' for R&D ... pledging to invest £2 million in a new facility, creating 20 jobs. In a further development, the government’s Strategic Priorities Fund will ...

Additionally, our marketplaces allow technology professionals to find their ideal next career opportunity ... the various attitudes company leaders have toward... at 16:20 IQVIA to Announce ...